drugset / Trial / NCT02824419

Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis

NCT02824419

Phase 2/3 Unknown 10 enrolled Turku University Hospital
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The goal of the current study is to evaluate the potential of the selected PET tracers to detect sarcoidotic lesions in lungs. The tracers are already in clinical use for the detection of certain inflammatory processes or malignant tumors, and their targets present similarities with molecular mechanisms of sarcoidosis.

Timeline

Start
2016-05
Primary completion
2017-05
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DOTANOC Small molecule
Subject Methionine Other / unclassified

Indications